EVALUATING THE EFFECTIVENESS OF 3C INTERVENTION MANAGEMENT ON HYPERTENSION IN ATHLETES: A COMMUNITY-BASED COMPARATIVE STUDY
Keywords:
Hypertension; Community Management; 3C Management Model; Target Organ Damage; Psychometric AssessmentAbstract
This study assesses the effectiveness of the 3C management model in managing hypertension among community members, with a specific focus on its applicability to athletes, who may face unique challenges in blood pressure management due to their high levels of physical activity. Methods: A total of 237 patients with essential hypertension were enrolled and divided into three groups: a 3C management group, a conventional management group, and a control group. The 3C model integrates comprehensive care, coordinated interventions, and continuous engagement, tailored to address the multifaceted needs of hypertensive patients. Results: Patients in the 3C management group demonstrated significant improvements in systolic and diastolic blood pressures. The reduction in target organ damage was notably higher in this group, with decreases in Cystatin C (Cys-c), Carotid Intima-Media Thickness (CIMT), and Left Ventricular Posterior Wall Thickness (LVPWT) by 28.57%, 12.50%, and 4.00% respectively, indicating better cardiovascular health. The standard scores on health-related quality of life scales such as HK-LS, ATRABS, and TAQPH also improved significantly, suggesting enhanced psychological and physical functioning. In contrast, the conventional and control groups showed lesser or no improvements in these parameters. Conclusions: The 3C management model significantly outperforms traditional approaches in controlling hypertension, reducing target organ damage, and improving overall health metrics in community settings. Its comprehensive and tailored approach makes it particularly advantageous for athletes, who require meticulous management of blood pressure to maintain optimal performance and health. The results advocate for broader clinical adoption and adaptation of the 3C model in sports medicine to effectively support athletes with hypertension.